KRAS and lung carcinoma: To explore the relevance of LPIAT1 in lung cancer, we investigated a lung adenocarcinoma cohort (subset LUAD that includes information on KRAS mutational status) from the The Cancer Genome Atlas (TCGA) database, to compare the gene expression of LPIAT1 between wild-type KRAS tumors, mutant KRAS tumors and healthy lung tissue [31].